Form 4: Orchestra BioMed Executive's Tax-Related Stock Transaction

Orchestra BioMed Holdings, Inc. executive Darren Sherman reported a tax-related disposition of 5,588 common shares at $4.31 per share, maintaining significant beneficial ownership.

Summary

• Darren Sherman, a Director, President, and Chief Operating Officer of Orchestra BioMed Holdings, Inc. (OBIO), reported a transaction on January 2, 2026.
• The transaction involved the disposition of 5,588 shares of common stock, par value $0.0001 per share.
• These shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• No shares were sold in the open market as a result of this transaction.
• The deemed price for the disposition was $4.31 per share.
• Following this transaction, Mr. Sherman beneficially owns 840,569 shares of Orchestra BioMed Holdings, Inc. common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax-related withholding of shares upon RSU vesting, not an open market sale, indicating a neutral impact on company fundamentals or executive confidence.

Positives

• The transaction was solely for tax withholding purposes, not an open market sale by the executive, indicating a routine compliance event.
• Darren Sherman retains significant beneficial ownership of 840,569 common shares, demonstrating continued alignment with shareholder interests.

Future Outlook

NA

Management Comments

• Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units.
• No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax withholding, not a discretionary sale by the executive.
• Employees: Reflects standard executive compensation practices involving restricted stock units.

Key Dates

Recommendation

The filing details a routine tax-related share withholding by an executive upon RSU vesting, which is a standard compensation event and does not reflect a change in the company's fundamentals or the executive's confidence. It provides no new information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Orchestra BioMed, OBIO, Darren Sherman, Form 4, insider transaction, stock withholding, restricted stock units, tax obligations